The cystic fibrosis transmembrane conductance regulator (CFTR) is a membrane protein that belongs to the same family as multidrug resistance-associated proteins whose main function is to expel xenobiotics and physiological organic anions from the cell interior. Despite the overall structural similarity with these membrane proteins, CFTR is not an active transporter but is instead a Cl- channel. We have tested the ability of known inhibitors of multidrug resistance-associated proteins to affect CFTR Cl- currents. We have found that sulfinpyrazone, probenecid, and benzbromarone are also inhibitors of CFTR activity, with a mechanism involving blockage of the channel pore.

Block of CFTR-dependent chloride currents by inhibitors of multidrug resistance-associated proteins / Diena, Tullia; Melani, Raffaella; Caci, Emanuela; Pedemonte, Nicoletta; Sondo, Elvira; Zegarra-Moran, Olga; Galietta, Luis J. V.. - In: EUROPEAN JOURNAL OF PHARMACOLOGY. - ISSN 0014-2999. - 560:2-3(2007), pp. 127-131. [10.1016/j.ejphar.2007.01.051]

Block of CFTR-dependent chloride currents by inhibitors of multidrug resistance-associated proteins

Galietta, Luis J. V.
2007

Abstract

The cystic fibrosis transmembrane conductance regulator (CFTR) is a membrane protein that belongs to the same family as multidrug resistance-associated proteins whose main function is to expel xenobiotics and physiological organic anions from the cell interior. Despite the overall structural similarity with these membrane proteins, CFTR is not an active transporter but is instead a Cl- channel. We have tested the ability of known inhibitors of multidrug resistance-associated proteins to affect CFTR Cl- currents. We have found that sulfinpyrazone, probenecid, and benzbromarone are also inhibitors of CFTR activity, with a mechanism involving blockage of the channel pore.
2007
Block of CFTR-dependent chloride currents by inhibitors of multidrug resistance-associated proteins / Diena, Tullia; Melani, Raffaella; Caci, Emanuela; Pedemonte, Nicoletta; Sondo, Elvira; Zegarra-Moran, Olga; Galietta, Luis J. V.. - In: EUROPEAN JOURNAL OF PHARMACOLOGY. - ISSN 0014-2999. - 560:2-3(2007), pp. 127-131. [10.1016/j.ejphar.2007.01.051]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/739028
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 14
  • ???jsp.display-item.citation.isi??? ND
social impact